Dorian A Stolk

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Basal Cell Carcinoma

High Resolution Mass Spectrometry

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Aram M de Haas, Dorian A Stolk, Sjoerd T T Schetters, Laura Goossens-Kruijssen, Eelco Keuning, Martino Ambrosini, Louis Boon, Hakan Kalay, Gerrit Storm, Hans J van der Vliet, Tanja D de Gruijl, Yvette van Kooyk
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells. Pharmaceutics 16 (5) (2024)
Aram M de Haas, Dorian A Stolk, Sjoerd T T Schetters, Laura Goossens-Kruijssen, Eelco Keuning, Martino Ambrosini, Louis Boon, Hakan Kalay, Gerrit Storm, Hans J van der Vliet, Tanja D de Gruijl, Yvette van Kooyk
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells. Pharmaceutics 16 (5) (2024)
Elisabetta Michielon, Marta López González, Dorian A Stolk, Joeke G C Stolwijk, Sanne Roffel, Taco Waaijman, Sinéad M Lougheed, Tanja D de Gruijl, Susan Gibbs
A Reconstructed Human Melanoma-in-Skin Model to Study Immune Modulatory and Angiogenic Mechanisms Facilitating Initial Melanoma Growth and Invasion. Cancers 15 (10) (2023)
Joanna Grabowska, Dorian A Stolk, Maarten K Nijen Twilhaar, Martino Ambrosini, Gert Storm, Hans J van der Vliet, Tanja D de Gruijl, Yvette van Kooyk, Joke M M den Haan
Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1. Vaccines 9 (1) (2021)